Fri, 16 Nov 2018 15:58:19: Bristol-Myers Squibb laying off 69 employees in Florida in push to 'focus resources'

Fri, 16 Nov 2018 14:45:41: Eli Lilly weighs $200M-plus sale of declining China drug portfolio: report

Fri, 16 Nov 2018 14:40:55: AstraZeneca's Imfinzi fails key Mystic trial in lung cancer. What now?

Fri, 16 Nov 2018 14:33:59: Takeda investors mount last-minute effort to stymie Shire deal: FT

Fri, 16 Nov 2018 14:11:04: After historic win, Lilly partner Chi-Med’s Elunate flops in lung cancer

Fri, 16 Nov 2018 08:50:20: FiercePharmaAsia—Samsung BioLogics' crisis; Merck's Gardasil supply; China’s vaccine solution

Thu, 15 Nov 2018 16:41:53: AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win

Thu, 15 Nov 2018 15:38:29: Lilly's third-to-market Emgality nets FDA 'breakthrough' in cluster headache

Thu, 15 Nov 2018 15:13:43: Novartis plans more ‘autonomy’ for Sandoz. But don't confuse that with a spinoff: report

Thu, 15 Nov 2018 14:44:13: Repeat violations stack up at Dr. Reddy's cancer drug plant

Thu, 15 Nov 2018 14:25:16: Johnson & Johnson scores back-to-back victories in talc mesothelioma cases

Wed, 14 Nov 2018 19:49:35: Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year

Wed, 14 Nov 2018 16:08:06: Pfizer rolls out Retacrit, a biosim to Amgen and J&J anemia blockbusters, at a big discount

Wed, 14 Nov 2018 14:47:55: Samsung BioLogics stock listing, CEO in jeopardy over accounting fraud

Wed, 14 Nov 2018 14:41:56: Pfizer falls short in U.K. patent appeal for blockbuster Lyrica

Wed, 14 Nov 2018 14:27:56: Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects

Wed, 14 Nov 2018 13:55:42: Merck's Keytruda picks up first-in-class survival win in esophageal cancer

Wed, 14 Nov 2018 13:37:47: Seniors want drug prices in ads. Young people? Eh, whatever: survey

Wed, 14 Nov 2018 03:26:30: Mitsubishi Tanabe spotlights overlooked teen ALS caregivers with artistic effort

Tue, 13 Nov 2018 19:44:12: Johnson & Johnson backs new Invokana CV nod with series of awareness tweets

Tue, 13 Nov 2018 15:50:13: AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries

Tue, 13 Nov 2018 15:06:50: AstraZeneca offloads RSV drug to Sobi for $1.5B, its largest divestiture in 5 years

Tue, 13 Nov 2018 14:42:44: Roche's Tecentriq blazes toward first-in-class breast cancer nod with FDA 'priority' tag

Tue, 13 Nov 2018 14:16:59: Express Scripts ramps up list-price pressure with newfangled 'Flex' formulary

Mon, 12 Nov 2018 16:21:22: Merck suits up for another Opdivo showdown with Keytruda liver cancer approval